 |
|
Imatinib
| |
Eosinophilia: Definitive therapy
Chronic Leukemia: Treatment
Commonly Used Antineoplastic Drugs
Modalities of Cancer Therapy:
Signal transduction inhibitors
Mastocytosis: Systemic mastocytosis
|
|
|
Imerslund-Graesbeck syndrome
| |
Disorders of Amino Acid and Organic Acid Metabolism
|
|
|
Imerslund-Gräsbeck syndrome
| |
Vitamin B12: Etiology
|
|
|
Iminoglycinuria
| |
Disorders of Amino Acid and Organic Acid Metabolism
|
|
|
Imipenem
| |
Usual Doses of Commonly Prescribed Antibiotics
β-Lactams: Other β-Lactams
|
|
|
in infective endocarditis
| |
Antibiotic Regimens for Endocarditis
|
|
|
neonatal dosage of
| |
Recommended Dosages of Selected Parenteral Antibiotics for Neonates
|
|
|
Imipramine
| |
Depressive Disorders:
Heterocyclic antidepressants
Antidepressants
|
|
|
drug interactions of
| |
Some Drugs With Potentially Serious Drug-Drug Interactions*
|
|
|
in elderly
| |
Effect of Aging on Drug Metabolism* and Elimination
|
|
|
hyperpigmentation and
| |
Hyperpigmentation Effects of Some Drugs and Chemicals
|
|
|
in nocturnal enuresis
| |
Incontinence in Children: Nocturnal enuresis
Drugs Used for Enuresis in Children*
|
|
|
poisoning with
| |
Symptoms and Treatment of Specific Poisons
|
|
|
in urinary incontinence
| |
Drugs Used to Treat Incontinence
Urinary Incontinence in Adults:
Stress incontinence
|
|
|
Imiquimod
| |
Chronic Effects of Sunlight: Actinic keratoses
|
|
|
Imiquimod cream
| |
|
|
|
in molluscum contagiosum
| |
Molluscum Contagiosum: Treatment
|
|
|
in warts
| |
Warts:
Flat warts
|
|
|
Immersion (trench) foot
| |
Nonfreezing Tissue Injuries:
Immersion (trench) foot
|
|
|
Immobilization
| |
|
|
|
in ankle sprain
| |
Sprains, Strains, and Tendon Tears:
Ankle sprains
|
|
|
in brain injury
| |
Traumatic Brain Injury (TBI): Treatment
|
|
|
hypercalcemia and
| |
Principal Causes of Hypercalcemia
Hypercalcemia: Pathophysiology
|
|
|
in knee sprain
| |
Knee Sprains and Meniscal Injuries: Treatment
|
|
|
in musculoskeletal trauma
| |
Fractures, Dislocations, and Sprains:
Immobilization
Joint immobilization as acute treatment: some commonly used techniques.
Fractures: Treatment
|
|
|
in snakebite
| |
Snakebites: General approach
|
|
|
in spinal trauma
| |
Spinal Trauma: Immediate care
|
|
|
in sprains and tears
| |
Sprains, Strains, and Tendon Tears: Treatment
|
|
|
urinary incontinence and
| |
Causes of Transient Incontinence
|
|
|
Immune complexes
| |
Allergic, Autoimmune, and Other Hypersensitivity Disorders:
Type III
|
|
|
in IgA nephropathy
| |
Immunoglobulin A Nephropathy (IgA Nephropathy)
|
|
|
in loiasis
| |
Filarial Nematode Infections: Symptoms and Signs
|
|
|
in lupus nephritis
| |
Lupus Nephritis: Pathophysiology
|
|
|
in membranoproliferative glomerulonephritis
| |
Electron microscopic features in immunologic glomerular disorders.
Membranoproliferative Glomerulonephritis
|
|
|
in membranous nephropathy
| |
Membranous Nephropathy: Diagnosis
|
|
|
in postinfectious glomerulonephritis
| |
Postinfectious Glomerulonephritis: Diagnosis
|
|
|
in rapidly progressive glomerulonephritis
| |
Classification of Rapidly Progressive Glomerulonephritis Based on Immunofluorescence Microscopy
Rapidly Progressive Glomerulonephritis (RPGN)
Rapidly Progressive Glomerulonephritis (RPGN): Diagnosis
Rapidly Progressive Glomerulonephritis (RPGN): Treatment
|
|
|
in rheumatoid arthritis
| |
Rheumatoid Arthritis (RA): Pathophysiology
|
|
|
in SLE
| |
Lupus Nephritis: Pathophysiology
|
|
|
Immune globulin
| |
Immune Globulins and Antitoxins* Available in the US
Passive Immunization:
Human immune globulin (IG)
|
|
|
cytomegalovirus
| |
Immune Globulins and Antitoxins* Available in the US
|
|
|
in Guillain-Barré syndrome
| |
Guillain-Barré Syndrome (GBS): Treatment
|
|
|
in hepatitis A
| |
Acute Viral Hepatitis:
HAV
|
|
|
in hepatitis B
| |
Acute Viral Hepatitis:
HBV
Common Vaccinations for Adults
|
|
|
in neonate
| |
Neonatal Hepatitis B Virus Infection: Prevention
|
|
|
in idiopathic thrombocytopenic purpura
| |
Immune Thrombocytopenia (ITP): Treatment
|
|
|
in IgA nephropathy
| |
Immunoglobulin A Nephropathy (IgA Nephropathy): Other treatments
|
|
|
in immunodeficiency
| |
Approach to the Patient With Suspected Immunodeficiency: Replacement of missing immune components
|
|
|
intravenous
| |
Common Vaccinations for Adults
Passive Immunization:
Human immune globulin (IG)
|
|
|
in Kawasaki disease
| |
Kawasaki Disease (KD): Treatment
|
|
|
in lymphocytopenia
| |
Lymphocytopenia: Treatment
|
|
|
in measles prevention
| |
Other Viruses: Postexposure prophylaxis
|
|
|
in multiple myeloma
| |
Multiple Myeloma: Treatment of complications
|
|
|
in myasthenia gravis
| |
Myasthenia Gravis:
Immunomodulating treatment
|
|
|
prophylactic
| |
Passive Immunization:
Human immune globulin (IG)
|
|
|
in low-birth-weight infant
| |
Neonatal Sepsis: Prevention
|
|
|
rabies
| |
Immune Globulins and Antitoxins* Available in the US
Rabies: Postexposure
|
|
|
respiratory syncytial virus
| |
Immune Globulins and Antitoxins* Available in the US
|
|
|
Rh0(D)
| |
Erythroblastosis Fetalis: Prevention
Postpartum Care and Associated Disorders:
Vaccination and Rh desensitization
|
|
|
Rh0(D)
| |
Blood Products: Immune globulins
Approach to the Pregnant Woman and Prenatal Care: Immunizations
|
|
|
in severe combined immunodeficiency
| |
Severe Combined Immunodeficiency (SCID): Treatment
|
|
|
tetanus
| |
Immune Globulins and Antitoxins* Available in the US
Tetanus:
Antitoxin
Tetanus Prophylaxis in Routine Wound Management
|
|
|
in toxic epidermal necrolysis
| |
Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN): Treatment
|
|
|
vaccination and
| |
Immunization: Risks, Restrictions, and High-Risk Groups
|
|
|
vaccinia
| |
Immune Globulins and Antitoxins* Available in the US
Smallpox: Vaccine complications
|
|
|
varicella vaccination and
| |
Routine Vaccinations: Administration
|
|
|
varicella-zoster
| |
Immune Globulins and Antitoxins* Available in the US
Chickenpox: Postexposure prophylaxis
|
|
|
in virus infections
| |
Viruses:
Immune globulins
|
|
|
Immune reconstitution inflammatory syndromes
| |
Human Immunodeficiency Virus (HIV):
Treatment
|
|
|
Immune response
| |
|
|
|
primary
| |
Components of the Immune System:
B cells
|
|
|
secondary (anamnestic, booster)
| |
Components of the Immune System:
B cells
|
|
|
Immune system
| |
see also Antibodies
see also Antigen(s)
see also Immunity
see also Immunodeficiency
see also Immunoglobulin(s)
see also Lymphocytes
Biology of the Immune System
Functions of T Cells
B-cell receptor.
Complement activation pathways.
|
|
|
aging-related changes in
| |
Biology of the Immune System: Geriatrics Essentials
Selected Physiologic Age-Related Changes
|
|
|
in cancer
| |
Tumor Immunology
|
|
|
in chronic fatigue syndrome
| |
Chronic Fatigue Syndrome: Etiology
|
|
|
neonatal
| |
Perinatal Physiology:
Immunologic function
|
|
|
in pulmonary infection
| |
Pneumonia
|
|
|
in rheumatoid arthritis
| |
Rheumatoid Arthritis (RA): Pathophysiology
|
|
|
Immune thrombocytopenia
| |
Immune Thrombocytopenia (ITP)
|
|
|
Immunity
| |
|
|
|
acquired (adaptive)
| |
Biology of the Immune System:
Acquired immunity
Host Defense Mechanisms Against Infection:
Specific Immune Responses
|
|
|
cellular
| |
Host Response to Tumors:
Cellular Immunity
|
|
|
complement in
| |
Complement System
Complement activation pathways.
|
|
|
disorders of
| |
see Allergy
see Compromised host
see Hypersensitivity reactions
see Immunodeficiency
|
|
|
human leukocyte antigens in
| |
Human Leukocyte Antigen (HLA) System
|
|
|
humoral
| |
Host Response to Tumors:
Humoral Immunity
|
|
|
innate (natural)
| |
Biology of the Immune System:
Innate immunity
Host Defense Mechanisms Against Infection:
Nonspecific Immune Responses
|
|
|
nutritional support response and
| |
Nutritional Support: Assessing Response to Nutritional Support
|
|
|
protein-energy undernutrition and
| |
Protein-Energy Undernutrition:
Primary PEU
Values Commonly Used to Grade the Severity of Protein-Energy Undernutrition
|
|
|
vitamin D effects on
| |
Actions of Vitamin D and Its Metabolites
|
|
|
Immunization
| |
see also Vaccination
|
|
|
hepatitis
| |
Vaccines for International Travel*,†
|
|
|
Japanese encephalitis
| |
Vaccines for International Travel*,†
|
|
|
meningococcal meningitis
| |
Vaccines for International Travel*,†
|
|
|
passive
| |
Common Vaccinations for Adults
Passive Immunization
Perinatal Physiology:
Immunologic function
|
|
|
rabies
| |
Vaccines for International Travel*,†
|
|
|
for travelers
| |
Vaccines for International Travel*,†
|
|
|
typhoid
| |
Vaccines for International Travel*,†
|
|
|
yellow fever
| |
Vaccines for International Travel*,†
|
|
|
Immunobead test
| |
Sperm Disorders: Diagnosis
|
|
|
Immunocompromised host
| |
see Compromised host
see Immunodeficiency
|
|
|
Immunodeficiency
| |
Immunodeficiency Disorders
|
|
|
B-cell
| |
Immunodeficiency Disorders:
Primary immunodeficiencies
Primary Immunodeficiency Disorders
Initial and Additional Laboratory Tests for Immunodeficiency
Advanced Laboratory Tests for Immunodeficiency
|
|
|
bronchiectasis and
| |
Factors Predisposing to Bronchiectasis
|
|
|
cancer and
| |
Cellular and Molecular Basis of Cancer: Immunologic Disorders
Ataxia-Telangiectasia
Wiskott-Aldrich Syndrome
|
|
|
combined
| |
Immunodeficiency Disorders:
Primary immunodeficiencies
Primary Immunodeficiency Disorders
|
|
|
common variable
| |
Primary Immunodeficiency Disorders
Characteristic Clinical Findings in Some Primary Immunodeficiency Disorders
Common Variable Immunodeficiency
|
|
|
eosinophilia and
| |
Important Disorders and Treatments Associated With Eosinophilia
|
|
|
HIV infection and
| |
see also Human immunodeficiency virus (HIV) infection
Human Immunodeficiency Virus (HIV)
Simplified HIV life cycle.
|
|
|
iatrogenic
| |
Causes of Secondary Immunodeficiency
Some Drugs That Cause Immunosuppression
|
|
|
in infant
| |
Approach to the Patient With Suspected Immunodeficiency
Characteristic Clinical Findings in Some Primary Immunodeficiency Disorders
|
|
|
infections in
| |
Approach to the Patient With Suspected Immunodeficiency
Some Clues in Patient History to Type of Immunodeficiency
Approach to the Patient With Suspected Immunodeficiency:
Management of acute infection
|
|
|
laboratory tests in
| |
Approach to the Patient With Suspected Immunodeficiency:
Initial testing
Initial and Additional Laboratory Tests for Immunodeficiency
Advanced Laboratory Tests for Immunodeficiency
|
|
|
mucocutaneous candidiasis
| |
Chronic Mucocutaneous Candidiasis
|
|
|
physical examination in
| |
Approach to the Patient With Suspected Immunodeficiency:
Physical examination
Characteristic Clinical Findings in Some Primary Immunodeficiency Disorders
|
|
|
physiologic
| |
Causes of Secondary Immunodeficiency
|
|
|
pneumonia and
| |
Pneumonia in Immunocompromised Patients
Pneumonia in Immunocompromised Patients
|
|
|
prenatal diagnosis of
| |
Approach to the Patient With Suspected Immunodeficiency:
Prenatal diagnosis
|
|
|
primary
| |
Immunodeficiency Disorders:
Primary immunodeficiencies
Primary Immunodeficiency Disorders
Some Clues in Patient History to Type of Immunodeficiency
Characteristic Clinical Findings in Some Primary Immunodeficiency Disorders
|
|
|
secondary
| |
Immunodeficiency Disorders:
Secondary immunodeficiencies
Causes of Secondary Immunodeficiency
Some Drugs That Cause Immunosuppression
|
|
|
severe combined
| |
Primary Immunodeficiency Disorders
Characteristic Clinical Findings in Some Primary Immunodeficiency Disorders
Advanced Laboratory Tests for Immunodeficiency
Approach to the Patient With Suspected Immunodeficiency: Prognosis
Severe Combined Immunodeficiency (SCID)
|
|
|
T-cell
| |
Immunodeficiency Disorders:
Primary immunodeficiencies
Primary Immunodeficiency Disorders
Initial and Additional Laboratory Tests for Immunodeficiency
Approach to the Patient With Suspected Immunodeficiency: Additional testing
Advanced Laboratory Tests for Immunodeficiency
Ataxia-Telangiectasia
|
|
|
Immunoelectrophoresis
| |
Immunologic Tests for Infectious Disease:
Precipitation tests
|
|
|
Immunofluorescence
| |
Microscopy:
Fluorescent stains
|
|
|
Immunoglobulin(s)
| |
see also Antibodies, and specific immunoglobulins
Plasma Cell Disorders: Pathophysiology
Components of the Immune System:
B cells
Components of the Immune System:
Antibodies
Host Defense Mechanisms Against Infection:
Specific Immune Responses
|
|
|
in amyloidosis
| |
Amyloidosis:
Primary amyloidosis (AL)
|
|
|
classes of
| |
Components of the Immune System:
Antibody classes
|
|
|
fetal
| |
Perinatal Physiology:
Immunologic function
|
|
|
in heavy chain diseases
| |
Classification of Plasma Cell Disorders
Heavy Chain Diseases
|
|
|
infection prevention and
| |
Host Defense Mechanisms Against Infection: Mucous membranes
|
|
|
liver disease and
| |
Laboratory Tests of the Liver and Gallbladder:
Serum immunoglobulins
|
|
|
in multiple myeloma
| |
Classification of Plasma Cell Disorders
Multiple Myeloma
|
|
|
structure of
| |
Components of the Immune System:
Antibodies
B-cell receptor.
|
|
|
Immunoglobulin A (IgA)
| |
Components of the Immune System:
Antibody classes
|
|
|
antibodies to
| |
IgA Deficiency: Symptoms and Signs
|
|
|
deficiency of
| |
Immunodeficiency Disorders:
Primary immunodeficiencies
Primary Immunodeficiency Disorders
Approach to the Patient With Suspected Immunodeficiency:
Initial testing
IgA Deficiency
|
|
|
pneumonia with
| |
Pneumonia in Immunocompromised Patients
|
|
|
deposition of
| |
|
|
|
cutaneous
| |
Linear Immunoglobulin A Disease
|
|
|
renal
| |
Immunoglobulin A Nephropathy (IgA Nephropathy)
|
|
|
heavy chain disease of
| |
Classification of Plasma Cell Disorders
Heavy Chain Diseases:
IgA Heavy Chain Disease
|
|
|
in pediatric HIV infection
| |
Human Immunodeficiency Virus (HIV) Infection in Infants and Children: Other tests
|
|
|
secretory
| |
Components of the Immune System:
Antibody classes
Host Defense Mechanisms Against Infection: Mucous membranes
|
|
|
bacterial inactivation of
| |
Factors Facilitating Microbial Invasion: Other factors
|
|
|
vasculitis and
| |
Immunoglobulin A–Associated Vasculitis (IgAV)
|
|
|
Immunoglobulin D (IgD)
| |
Components of the Immune System:
Antibody classes
|
|
|
excessive
| |
Hyper-IgD Syndrome
|
|
|
heavy chain disease of
| |
Classification of Plasma Cell Disorders
|
|
|
Immunoglobulin E (IgE)
| |
Components of the Immune System:
Antibody classes
|
|
|
angioedema and
| |
Angioedema: Acute angioedema
|
|
|
assessment of
| |
Advanced Laboratory Tests for Immunodeficiency
|
|
|
in asthma
| |
Asthma and Related Disorders: Other tests
Asthma and Related Disorders: Drug therapy
|
|
|
in bronchopulmonary aspergillosis
| |
Allergic Bronchopulmonary Aspergillosis (ABPA): Diagnosis
|
|
|
excessive
| |
Primary Immunodeficiency Disorders
Characteristic Clinical Findings in Some Primary Immunodeficiency Disorders
Hyper-IgE Syndrome
|
|
|
in food allergy
| |
Food Allergy: Etiology
|
|
|
receptors for
| |
Components of the Immune System:
Polymorphonuclear Leukocytes
|
|
|
serum
| |
Allergic, Autoimmune, and Other Hypersensitivity Disorders: Nonspecific tests
|
|
|
in type I hypersensitivity reactions
| |
Allergic, Autoimmune, and Other Hypersensitivity Disorders:
Type I
|
|
|
Immunoglobulin G (IgG)
| |
Components of the Immune System:
Antibody classes
|
|
|
assessment of
| |
Approach to the Patient With Suspected Immunodeficiency:
Initial testing
|
|
|
complement fixation test of
| |
Immunologic Tests for Infectious Disease:
Complement fixation
|
|
|
deficiency of
| |
Approach to the Patient With Suspected Immunodeficiency:
Initial testing
|
|
|
bronchiectasis and
| |
Factors Predisposing to Bronchiectasis
|
|
|
pneumonia and
| |
Pneumonia in Immunocompromised Patients
|
|
|
heavy chain disease of
| |
Classification of Plasma Cell Disorders
Heavy Chain Diseases:
IgG Heavy Chain Disease
|
|
|
in hemolytic anemia
| |
Autoimmune Hemolytic Anemia: Diagnosis
|
|
|
infection prevention and
| |
Host Defense Mechanisms Against Infection: Mucous membranes
|
|
|
in multiple sclerosis
| |
Multiple Sclerosis (MS): Diagnosis
|
|
|
in pediatric HIV infection
| |
Human Immunodeficiency Virus (HIV) Infection in Infants and Children: Other tests
|
|
|
subclasses of
| |
Components of the Immune System:
Antibody classes
|
|
|
Immunoglobulin M (IgM)
| |
Components of the Immune System:
Antibody classes
|
|
|
assessment of
| |
Approach to the Patient With Suspected Immunodeficiency:
Initial testing
|
|
|
complement fixation test of
| |
Immunologic Tests for Infectious Disease:
Complement fixation
|
|
|
deficiency of
| |
Approach to the Patient With Suspected Immunodeficiency:
Initial testing
|
|
|
pneumonia and
| |
Pneumonia in Immunocompromised Patients
|
|
|
heavy chain disease of
| |
Classification of Plasma Cell Disorders
Heavy Chain Diseases:
IgM Heavy Chain Disease
|
|
|
in hepatitis A
| |
Hepatitis A Serology
|
|
|
immunodeficiency and
| |
Primary Immunodeficiency Disorders
Hyper-IgM Syndrome
|
|
|
Immunomodulating drugs
| |
see also Immunosuppressants
see also Immunotherapy
|
|
|
in asthma
| |
Asthma and Related Disorders: Drug therapy
|
|
|
in atopic dermatitis
| |
Atopic Dermatitis:
Other therapies
|
|
|
in inflammatory bowel disease
| |
Inflammatory Bowel Disease (IBD):
Immunomodulating drugs
|
|
|
in myasthenia gravis
| |
Myasthenia Gravis:
Immunomodulating treatment
|
|
|
in psoriasis
| |
Psoriasis:
Systemic treatments
|
|
|
Immunoreactive trypsinogen
| |
Cystic Fibrosis (CF):
Newborn screening
|
|
|
Immunosuppressants
| |
see also Immunomodulating drugs
|
|
|
cancer and
| |
Transplantation:
Cancer
|
|
|
echinacea interactions with
| |
Some Possible Dietary Supplement–Drug Interactions*
|
|
|
in multiple sclerosis
| |
Multiple Sclerosis (MS): Disease-modifying drugs
|
|
|
in myositis
| |
Polymyositis and Dermatomyositis:
Treatment
|
|
|
in pemphigus vulgaris
| |
Pemphigus Vulgaris: Treatment
|
|
|
in psoriasis
| |
Psoriasis:
Systemic treatments
|
|
|
in pulmonary-renal syndrome
| |
Pulmonary-Renal Syndrome: Treatment
|
|
|
in red blood cell aplasia
| |
Aplastic Anemia: Treatment
|
|
|
in relapsing polychondritis
| |
Relapsing Polychondritis: Treatment
|
|
|
in rheumatoid arthritis
| |
Other Drugs Used to Treat Rheumatoid Arthritis
Rheumatoid Arthritis (RA):
Immunomodulatory, cytotoxic, and immunosuppressive drugs
|
|
|
in SLE
| |
Systemic Lupus Erythematosus (SLE): Severe disease
Protocol for Chemotherapy With Cyclophosphamide and IV Mesna
|
|
|
in systemic sclerosis
| |
Systemic Sclerosis: Treatment
|
|
|
in transplantation
| |
Transplantation:
Immunosuppression
Transplantation: Future therapies
|
|
|
vaccination and
| |
Immunization: Risks, Restrictions, and High-Risk Groups
|
|
|
Immunosuppression
| |
see Compromised host
see Immunodeficiency
|
|
|
Immunotactoid glomerulopathy
| |
Fibrillary and Immunotactoid Glomerulopathies
|
|
|
Immunotherapy
| |
Immunotherapeutics
Some Immunotherapeutic Agents in Clinical Use*
|
|
|
in allergic rhinitis
| |
Allergic Rhinitis: Treatment
|
|
|
in allergy
| |
Allergic, Autoimmune, and Other Hypersensitivity Disorders:
Immunotherapy
|
|
|
in asthma
| |
Asthma and Related Disorders: Drug therapy
|
|
|
in bee sting allergy
| |
Insect Stings: Prevention
|
|
|
in cancer
| |
Immunotherapy of Cancer
|
|
|
in drug hypersensitivity
| |
Drug Hypersensitivity:
Desensitization
|
|
|
in drug-induced serum sickness
| |
Drug Hypersensitivity:
Desensitization
|
|
|
Imperforate anus
| |
Anal Atresia
|
|
|
Impetigo
| |
Impetigo and Ecthyma
Streptococcal Infections: Diseases Caused by Streptococci
|
|
|
Implantable cardioverter-defibrillator
| |
Heart Failure:
Device therapy
Arrhythmias and Conduction Disorders:
Implantable cardioverter-defibrillators (ICDs)
Indications for Implantable Cardioverter-Defibrillators in Ventricular Tachycardia and Ventricular Fibrillation
Ventricular Tachycardia (VT):
Long-term
|
|
|
after resuscitation
| |
Cardiopulmonary Resuscitation (CPR) in Adults:
Dysrhythmia treatment
|
|
|
magnetic resonance imaging and
| |
Magnetic Resonance Imaging:
Magnetic field
|
|
|
Impotence
| |
Erectile Dysfunction
|